Short Interest in Alphatec Holdings, Inc. (ATEC) Decreases By 30.4%

Alphatec Holdings, Inc. (NASDAQ:ATEC) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 791,509 shares, a decrease of 30.4% from the November 30th total of 1,137,916 shares. Based on an average trading volume of 149,012 shares, the days-to-cover ratio is presently 5.3 days. Approximately 8.2% of the shares of the stock are short sold.

Several research firms have issued reports on ATEC. HC Wainwright reiterated a “buy” rating and set a $4.00 price objective on shares of Alphatec in a research note on Wednesday, November 22nd. Lake Street Capital assumed coverage on Alphatec in a research note on Monday, October 16th. They issued a “buy” rating and a $7.00 target price for the company. Finally, ValuEngine lowered Alphatec from a “sell” rating to a “strong sell” rating in a research note on Friday, December 1st.

Large investors have recently made changes to their positions in the company. Fondren Management LP increased its stake in shares of Alphatec by 20.8% in the second quarter. Fondren Management LP now owns 220,534 shares of the medical technology company’s stock valued at $408,000 after buying an additional 37,933 shares in the last quarter. Sabby Management LLC acquired a new stake in shares of Alphatec in the second quarter valued at $629,000. Finally, Broadfin Capital LLC increased its stake in shares of Alphatec by 163.1% in the second quarter. Broadfin Capital LLC now owns 594,533 shares of the medical technology company’s stock valued at $1,100,000 after buying an additional 368,527 shares in the last quarter. Institutional investors own 15.70% of the company’s stock.

Shares of Alphatec (ATEC) opened at $3.00 on Friday. Alphatec has a 12 month low of $1.58 and a 12 month high of $5.80. The firm has a market capitalization of $49.67, a price-to-earnings ratio of -1.36 and a beta of 1.35. The company has a quick ratio of 1.08, a current ratio of 2.11 and a debt-to-equity ratio of -1.11.

ILLEGAL ACTIVITY NOTICE: “Short Interest in Alphatec Holdings, Inc. (ATEC) Decreases By 30.4%” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://stocknewstimes.com/2018/01/06/short-interest-in-alphatec-holdings-inc-atec-decreases-by-30-4.html.

Alphatec Company Profile

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply